Sifi Mexico – Juan José Davidovich, General Manager
Juan José Davidovich, general manager of the Italian ophthalmology leader Sifi, speaks about the importance of Mexico as a base to enter Latin America and sets the goal of prospering…
SIFI has made the history of ophthalmology in Italy and has worked in the eye care sector since 1935. Italian market leader for over 15 years, it develops, produces and markets innovative pharmaceutical treatments, tools for diagnosis and surgical devices for prevention and care of the most common ocular pathologies. Since its foundation in 1935, SIFI has displayed a constant commitment to working alongside ophthalmologists. Being close to practitioners, sharing their passion for EyeCare and contributing to the improvement of disease management in ophthalmology is indeed SIFI’s principal concern. The development plans for Latin America has included the constitution in 2007 of a fully owned subsidiary, Laboratorios SIFI de México, which aims to become one of the main players in the local ophthalmic pharmaceutical sector.
Contact details
SIFI de México
Dante 36, Piso 11, Oficina 1101
Col. Anzures, Del. Miguel Hidalgo
CP 11590 México DF
MÉXICO
Tel: +52 (55) 5263 2450
Website: www.sifi.it
Juan José Davidovich, general manager of the Italian ophthalmology leader Sifi, speaks about the importance of Mexico as a base to enter Latin America and sets the goal of prospering…
Pedro Casas Alatriste of AmCham Mexico delves into the chamber’s efforts to enhance U.S.-Mexico trade relations, support key industries, and promote sustainable growth amid Mexico’s political transition. We are…
David López García, a pharma industry executive and rare disease expert, discusses the challenges and advancements in treating rare diseases in Mexico. He highlights the importance of public-private partnerships and…
Stendhal Pharma operates with an “unlimited pipeline” approach by forming strategic alliances with global pharmaceutical companies that lack a presence in Latin America. Rodrigo Ruiz Mingramm explains how, as companies…
The Swiss Chamber in Mexico (SwissCham) represents Swiss companies operating in Mexico, a country that has become Switzerland’s top commercial partner in Latin America. Executive Director Emilia Pfeiffer outlines the…
The Mexican Association of Pharmaceutical Research Industries (AMIIF) represents more than 60 of the country’s research-based pharmaceutical companies. Executive director Larry Rubin, who took on the association’s leadership six months…
Gilead’s Mexican affiliate is its largest in the LatAm region, and one that has had an impressive impact as 85 percent of those living with HIV in the country are…
Vincenzo D’Elia discusses the creation of Alfasigma’s Mexican affiliate – now solidly established after 14 years – and the company’s local strategy and market approach. He emphasizes the importance of…
Mexico has become a major player in global manufacturing, attracting companies looking to bring supply chains closer to North American markets, but home-grown pharma companies are also capitalizing on the…
Wiener Lab is a leader in diagnostics, with a strong focus on clinical chemistry, immunology, coagulation, and molecular biology. As Héctor Barillas Soto explains, the company has a significant presence…
Adium Mexico, recently rebranded to reflect the identity of the broader Adium Group, represents no less than 25 percent of the LatAm group’s sales. General Director José Miguel Fonken Quiroga…
Johannes Hauser, managing director of the German-Mexican Chamber of Commerce and Industry (AHK Mexico, or CAMEXA locally), shares the chamber’s functions, which include representing the German private sector in Mexico,…
Dr Jesus Navarro explains how his personal experience with his daughter’s rare disease led him to form the Mexican Organization for Rare Diseases (OMER) to support others facing similar challenges.…
See our Cookie Privacy Policy Here
